Ltd. The authors Amarnath Sugumaran, Senthilnathan Mohanasundaram, Jaideep Gogtay are permanent employees of Cipla Ltd, India. The remaining authors have no competing interest to declare that could appear to have influenced the submitted work....
First, 4–16% of children with severe malaria have bacterial co-infection, which is largely due to enteric Gram-negative organisms with a predominance of non-typhoidal salmonella (NTS) species [4]. Children with co-infection have substantially higher case fatality, estimated at 24% compared to ...
Those measures may take the form of technical controls such as encryption or anonymization of data. The PIA analysis is a self-declarative analysis. In France, the local GDPR representative (Commission Informatique et Liberté, CNIL) has provided a software to guide the reflexion around security ...
From 2012, the fixed-dose combination will be manufactured and registered by Cipla in India, which will accelerate uptake [48]. WHO prequalification was obtained in September 2012. Currently the market price of mefloquine (over $1,000/kg) makes this combination the most expensive ACT, however ...
Bristol Myers Squibb Reports Fourth Quarter Revenues of $11.1 Billion; Full-Year Revenues of $42.5 Billion Posts Fourth Quarter Loss Per Share of $4.45 and Non-GAAP EPS of $1.46; Full-Year Loss Per Share of $3.99 and Non-GAAP EPS of $6.44 Completes Acquisition of MyoKardia...
Finally, the in vivo antifungal efficacy of the selected EFN topical formulation was assessed in a T. mentagrophytes-infected guinea pig onychomycosis model. 2. Materials and methods 2.1. Materials EFN was obtained from Cipla Limited (Mumbai, India). Transcutol P was obtained from Gattefosse (...
In December, the company announced that its wholly owned subsidiary, Celgene, and Cipla Limited (Cipla) have settled their litigation related to patents for REVLIMID® (lenalidomide). (link) Inrebic® Regulatory In December, the company announced the Committee for Medicinal Products...
In December, the company announced that its wholly owned subsidiary, Celgene, and Cipla Limited (Cipla) have settled their litigation related to patents for REVLIMID® (lenalidomide). (link) Inrebic® Regulatory In December, the company announced the Committee for Medicinal Products for Human ...
Cipla, GlaxoSmithKline, Kyorin, Meda, Merck, Mundipharma, Novartis, Pfizer, SkyePharma, Takeda, and Teva; Payment for manuscript preparation: Mundipharma and Teva; Patents (planned, pending or issued): AKL Ltd.; Payment for the development of educational materials: GlaxoSmithKline, Novartis; Stock/St...
and Digestive and Kidney Diseases, and the Fogarty International Centre, as part of the International Epidemiology Databases to Evaluate AIDS (IeDEA; U01AI069907), the NIH-funded Johns Hopkins Baltimore-Washington-India Clinical Trials Unit for NIAID Networks [UM1AI069465] and Cipla Foundation, India...